Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche span> par promoteur : Biogen Idec Research Limited
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
A Clinical Study of the Safety and Efficacy of Natalizumab in Acute Ischemic Stroke Un ensayo clínico de la seguridad y eficacia de Natalizumab en el accidente cerebrovascular isquémico agudo
The primary objective of the study is to assess the effects of natalizumab versus placebo in acute ischemic stroke on clinical measures of independence and activities of daily life El objetivo p...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
Long-Term Prolonged-Release Fampridine Treatment and Quality of Life
The primary objective of the study is to assess the effect of long-term treatment with prolonged-release fampridine 10 mg twice daily on the physical component scale (PCS) of the Short Form (36) Healt...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
Study to Evaluate the Efficacy and Safety of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
The primary objective of the study is to evaluate the efficacy of 2 dose regimens of BIIB074 on neuropathic pain in subjects with PLSR.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
Prolonged-Release Fampridine Effect on Walking Ability and Balance in Multiple Sclerosis
The objectives of this study in MS subjects treated with prolonged-release fampridine 10 mg twice daily compared with subjects treated with placebo are: To assess the effect of prolonged-release fam...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
A study to assess the safety and efficacy of BIIB033 in patients with relapsing forms of multiple sclerosis when used concurrently with Avonex® Studio per valutare la sicurezza e l’efficacia di BIIB033 in pazienti con forme recidivanti di sclerosi multipla quando usato insieme a Avonex
The primary objective of the study is to evaluate the efficacy of BIIB033 in subjects with active relapsing MS when used concurrently with Avonex. E.2.1 Obiettivo principale: L'obiettivo pri...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With relapsing-remitting multiple sclerosis (RRMS)
The main objectives of Part 1 are as follows: • To evaluate the safety, tolerability, and effect on the disease course of BG00012 (dimethyl fumarate) in pediatric subjects with RRMS, as compared wi...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
A Study that evaluates Fatigue in Multiple Sclerosis Patients taking Tecfidera® (Dimethyl Fumarate)
The primary objective of this study is to determine whether DMF taken over 12 months is effective in reducing MS related fatigue, as measured by mean changes in the Fatigue Scale for Motor and Cogniti...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
A Study of Multiple Doses of ISIS ISIS 396443 Delivered to Infants with Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy Uno studio di dosi multiple di ISIS 396443 somministrato a neonati con atrofia muscolare spinale in fase presintomatica geneticamente diagnosticata
The primary objective of the study is to examine the efficacy of multiple doses of ISIS 396443 administered intrathecally in preventing or delaying the need for respiratory intervention or death in in...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
A Study that evaluates effectiveness of Tecfidera® (Dimethyl Fumarate) in Multiple Sclerosis Patients in a Real World Setting
The primary objective of the study is to estimate the annualized relapse rate (ARR) in subjects with RRMS who are treated with DMF over a 12-month period.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 5 ans
A study to evaluate the effect of aspirin on flushing in patients with RRMS treated with Tecfidera
The primary objective of the study is to evaluate whether 150 mg enteric-coated ASA taken BID with DMF administration or 75 mg enteric-coated ASA taken once daily in the morning (QAM) with DMF adminis...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
Suivant